Company logo

Yield10 Bioscience

Crop science
Innovations in crop yield
Agtech
Gene editing
Genome editing

Yield10 Bioscience information

Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aqua...
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics. Our commercial plan is based on establishing a grain contracting business leveraging our proprietary elite Camelina seed varieties, focusing on the growing demand for low-carbon intensity feedstock oil for biofuels and omega-3 oils for nutritional applications. The company is traded on Nasdaq with the symbol YTEN. Yield10 is headquartered in Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc., located in Saskatoon, Canada.

Employees

Karen Bohmert-Tatarev
Senior Director of Regulatory Affairs
Willie Loh
Director
Kristi Snell
Chief Science Officer and Vice President of Research
Rachel Cay
Research Associate
Frank Skraly
Consultant

Looking for a particular Yield10 Bioscience Employee?

Yield10 Bioscience's financial review

Yield10 Bioscience's Revenue (Yearly)

60K

Total Funding

21.1M

Nasdaq

YTEN

Employees

48

Last Funding Round

3.7M

Market cap

3.9M


Technologies

Amazon AWS
Hosting
Mixpanel
Analytics and Tracking
Mapbox
Other
Google Analytics
Analytics and Tracking

Alumni

Celeste Mastin
CEO and President
H.B. Fuller
Chris McChalicher
Vice President, CMC Technology Development
Seres Therapeutics
Dong-Eun Chang
Non Executive Advisor
CJ CheilJedang
Doug Bisson
Senior Scientist
Resilience
Mike Andrews
Process Technology and Application Development
Windmoeller & Hoelscher Group

Employees

Karen Bohmert-Tatarev
Senior Director of Regulatory Affairs
Willie Loh
Director
Kristi Snell
Chief Science Officer and Vice President of Research
Rachel Cay
Research Associate
Frank Skraly
Consultant

Looking for a particular Yield10 Bioscience Employee?

Yield10 Bioscience's financial review

Yield10 Bioscience's Revenue (Yearly)

60K

Total Funding

21.1M

Nasdaq

YTEN

Employees

48

Last Funding Round

3.7M

Market cap

3.9M


Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Represents linkedin prospector

See why over 1,000,000

people joined Apollo last year

Evolve your team’s engagement & intelligence today.